Cross priming or direct priming: Is that really the question?

Current Opinion in Immunology

Volumn 15, Issue 1, 2003, Pages 82-88

  Norbury, Christopher C ^a   Sigal, Luis J ^b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; HLA ANTIGEN CLASS 1; TUMOR ANTIGEN; VIRUS ANTIGEN;

ANTIGEN PRESENTING CELL; IMMUNIZATION; IN VITRO STUDY; QUESTIONNAIRE; REVIEW; T LYMPHOCYTE; VIRUS; ANIMAL; ANTIGEN PRESENTATION; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, NEOPLASM; ANTIGENS, VIRAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0037290763     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952791502000031     Document Type: Review

References (56)

1. Staerz U.D., Karasuyama H., Garner A.M. Cytotoxic T lymphocytes against a soluble protein. Nature. 329:1987;449-451.
2. Bevan M.J. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J. Immunol. 117:1976;2233-2238.
3. Bevan M.J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143:1976;1283-1288.
4. Heath W.R., Carbone F.R. Cross-presentation in viral immunity and self-tolerance. Nature Rev. Immunol. 1:2001;126-134.
5. Heath W.R., Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19:2001;47-64.
6. Zinkernagel R.M., Kreeb G., Althage A. Lymphohemopoietic origin of the immunogenic, virus-antigen-presenting cells triggering anti-viral T-cell responses. Clin. Immunol. Immunopathol. 15:1980;565-576.
7. Huang A.Y., Golumbek P., Ahmadzadeh M., Jaffee E., Pardoll D., Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science. 264:1994;961-965.
8. Sigal L.J., Crotty S., Andino R., Rock K.L. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature. 398:1999;77-80.
9. Sigal L.J., Rock K.L. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation. J. Exp. Med. 192:2000;1143-1150.
10. Lenz L.L., Butz E.A., Bevan M.J. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens. J. Exp. Med. 192:2000;1135-1142.
11. + T cells.
12. Kundig T.M., Bachmann M.F., DiPaolo C., Simard J.J., Battegay M., Lother H., Gessner A., Kuhlcke K., Ohashi P.S., Hengartner H.et al. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science. 268:1995;1343-1347.
13. Ochsenbein A.F., Sierro S., Odermatt B., Pericin M., Karrer U., Hermans J., Hemmi S., Hengartner H., Zinkernagel R.M. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature. 411:2001;1058-1064.
14. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2:2001;415-422.
15. van Stipdonk M.J., Lemmens E.E., Schoenberger S.P. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2:2001;423-429.
16. Kurts C., Cannarile M., Klebba I., Brocker T. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J. Immunol. 166:2001;1439-1442.
17. - dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192:2000;1685-1696.
18. + dendritic cells. J. Immunol. 166:2001;5327-5330.
19. - dendritic cell subset by a maturation process involving CD8α, DEC-205, and CD24 up-regulation. Blood. 99:2002;999-1004.
20. Traver D., Akashi K., Manz M., Merad M., Miyamoto T., Engleman E.G., Weissman I.L. Development of CD8α-positive dendritic cells from a common myeloid progenitor. Science. 290:2000;2152-2154.
21. Merad M., Fong L., Bogenberger J., Engleman E.G. Differentiation of myeloid dendritic cells into CD8α-positive dendritic cells in vivo. Blood. 96:2000;1865-1872.
22. + T cells.
23. MacDonald G.H., Johnston R.E. Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. J. Virol. 74:2000;914-922.
24. Ryan S., Tiley L., McConnell I., Blacklaws B. Infection of dendritic cells by the Maedi-Visna lentivirus. J. Virol. 74:2000;10096-10103.
25. Wu S.J., Grouard-Vogel G., Sun W., Mascola J.R., Brachtel E., Putvatana R., Louder M.K., Filgueira L., Marovich M.A., Wong H.K.et al. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6:2000;816-820.
26. Yewdell J.W., Bennink J.R. Mechanisms of viral interference with MHC class I antigen processing and presentation. Annu. Rev. Cell. Dev. Biol. 15:1999;579-606.
27. Kaiserlian D., Dubois B. Dendritic cells and viral immunity: friends or foes? Semin. Immunol. 13:2001;303-310.
28. Prasad S.A., Norbury C.C., Chen W., Bennink J.R., Yewdell J.W. Cutting edge: recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells. J. Immunol. 166:2001;4809-4812.
29. + T cells that is correlated with the appearance of cells presenting HSV antigen in the lymph node. Importantly, antigen presentation does not require the concomitant presence of viral DNA. This points to an important role for cross-presentation in HSV infection.
30. + T cell responses directed to this epitope. These data indicate that cross-presentation can overcome viral evasion strategies that downregulate MHC class I expression in infected cells, and that the immunodominance hierarchy may not be affected by this diversion into the cross priming pathway.
31. + T cells. J. Immunol. 168:2002;5403-5408.
32. Bronte V., Carroll M.W., Goletz T.J., Wang M., Overwijk W.W., Marincola F., Rosenberg S.A., Moss B., Restifo N.P. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc. Natl. Acad. Sci. U.S.A. 94:1997;3183-3188.
33. Corr M., Lee D.J., Carson D.A., Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184:1996;1555-1560.
34. Iwasaki A., Torres C.A., Ohashi P.S., Robinson H.L., Barber B.H. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J. Immunol. 159:1997;11-14.
35. Condon C., Watkins S.C., Celluzzi C.M., Thompson K., Falo L.D. Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2:1996;1122-1128.
36. + T cells after gene gun immunization. J. Exp. Med. 188:1998;1075-1082.
37. + T cell priming after gene gun immunization.
38. Antoniou AN, Powis SJ, Elliott T: Assembly and export of MHC class I peptide ligands. Curr Opin Immunol 2003, in press.
39. Snyder H.L., Bacik I., Bennink J.R., Kearns G., Behrens T.W., Bachi T., Orlowski M., Yewdell J.W. Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing. J. Exp. Med. 186:1997;1087-1098.
40. Bacik I., Cox J.H., Anderson R., Yewdell J.W., Bennink J.R. TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide. J. Immunol. 152:1994;381-387.
41. Esquivel F., Yewdell J., Bennink J. RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes. J. Exp. Med. 175:1992;163-168.
42. Zhou X., Glas R., Liu T., Ljunggren H.G., Jondal M. Antigen processing mutant T2 cells present viral antigen restricted through H-2Kb. Eur J. Immunol. 23:1993;1802-1808.
43. Zhou X., Glas R., Momburg F., Hammerling G.J., Jondal M., Ljunggren H.G. TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes. Eur. J. Immunol. 23:1993;1796-1801.
44. Huang A.Y., Bruce A.T., Pardoll D.M., Levitsky H.I. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity. 4:1996;349-355.
45. + T cells in vivo. J. Immunol. 166:2001;4355-4362.
46. - dendritic cells: a dispensable role for TAP. Eur J. Immunol. 32:2002;818-825.
47. Wick M.J., Pfeifer J.D. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation. Eur J. Immunol. 26:1996;2790-2799.
48. Schubert U., Anton L.C., Gibbs J., Norbury C.C., Yewdell J.W., Bennink J.R. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature. 404:2000;770-774.
49. Larsson M., Fonteneau J.F., Bhardwaj N. Dendritic cells resurrect antigens from dead cells. Trends Immunol. 22:2001;141-148.
50. Li Z., Menoret A., Srivastava P. Roles of heat-shock proteins in antigen presentation and cross-presentation. Curr. Opin. Immunol. 14:2002;45-51.
51. Vabulas R.M., Braedel S., Hilf N., Singh-Jasuja H., Herter S., Ahmad-Nejad P., Kirschning C.J., Da Costa C., Rammensee H.G., Wagner H.et al. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J. Biol. Chem. 277:2002;20847-20853.
52. Zheng H., Dai J., Stoilova D., Li Z. Cell surface targeting of heat shock protein gp96 induces dendritic cell maturation and antitumor immunity. J. Immunol. 167:2001;6731-6735.
53. Singh-Jasuja H., Scherer H.U., Hilf N., Arnold-Schild D., Rammensee H.G., Toes R.E., Schild H. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur. J. Immunol. 30:2000;2211-2215.
54. den Haan J.M., Bevan M.J. Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo. J. Exp. Med. 196:2002;817-827.
55. Jung S., Unutmaz D., Wong P., Sano G., De los Santos K., Sparwasser T., Wu S., Vuthoori S., Ko K., Zavala F.et al. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity. 17:2002;211-220 Now in press.
56. Ramirez MC, Sigal LJ: Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells. J Immunol 2002, in press.